Utilization, duration, and outcomes of neoadjuvant endocrine therapy in the United States

Overview of attention for article published in Breast Cancer Research and Treatment, August 2019

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (61st percentile)
Above-average Attention Score compared to outputs of the same age and source (61st percentile)

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 18,215 followers.

RT @YaleCancer: New findings in #breastcancer research journal led by .@SMougalian and Dr. Bridget Killela finds women receiving neoadjuvan…

RT @YaleCancer: New findings in #breastcancer research journal led by .@SMougalian and Dr. Bridget Killela finds women receiving neoadjuvan…

RT @YaleCancer: New findings in #breastcancer research journal led by .@SMougalian and Dr. Bridget Killela finds women receiving neoadjuvan…

New findings in #breastcancer research journal led by .@SMougalian and Dr. Bridget Killela finds women receiving neoadjuvant #endocrinetherapy had simliar rates of breast conservation surgery compared to neoadjuvant #chemotherapy. @YaleMed @YNHH https://t.